Justin J. McAnear, Chief Financial Officer at 10x Genomics, Inc. (TXG), sold 10,000 shares at $192.95 ($1.9M) on 2021-07-01, disclosed to the SEC on 2021-07-06.
Open-market sale of $1.9M TXG by Chief Financial Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $189.85 | 2,700 | $513K | 26.8% |
| 2 | $190.66 | 2,800 | $534K | 27.9% |
| 3 | $191.73 | 1,500 | $288K | 15.0% |
| 4 | $192.95 | 800 | $154K | 8.1% |
| 5 | $193.76 | 1,400 | $271K | 14.2% |
| 6 | $194.81 | 700 |
| $136K |
| 7.1% |
| 7 | $195.82 | 100 | $20K | 1.0% |
| Total | $191.56 avg | 10,000 | $1.9M | 100% |
| Filing → |
| TXG | SELL | 2024-02-26 | $173K | — | Filing → |
| TXG | SELL | 2023-11-27 | $146K | — | Filing → |
| TXG | SELL | 2023-08-24 | $154K | — | Filing → |